Bioquell and COVID-19
Learn more about Bioquell and Ecolabs response, our solutions, the latest news, and key information about the COVID-19 pandemic.
China International Biopharma4.0 Summit(2020) will further deepen topics concerning the implementation of specific policies and regulations on the biological cell culture technology, protein characterization and optimization and ICH-Q series, and discuss more practical topics such as Pharma 4.0, the latest progress in technologies, future trends, digitization and intelligence of biopharma companies, CGMP quality management system from laboratories to plants, regulations on the use of SUS, optimization of cell culture technology, advanced experience of upstream and downstream biopharma technology, and outsourcing technology development IP. Bioquell will be an advertising sponsorship on this event.